Table 2.
Variables | Univariate | Multivariate | ||||
---|---|---|---|---|---|---|
HR | 95% Cl | P | HR | 95% Cl | P | |
Age, y (>65 vs ≤65) | 0.97 | 0.45‐2.09 | .93 | |||
Gender (male vs female) | 0.54 | 0.26‐1.15 | .54 | |||
Smoking (no vs yes) | 0.59 | 0.28‐1.27 | .18 | |||
Histology (squamous vs nonsquamous) | 2.22 | 1‐4.93 | .05 | 2.49 | 1.12‐5.56 | .026 |
T status (T3‐4 vs T1‐2) | 1.34 | 0.64‐2.82 | .44 | |||
N status (N1‐3 vs N0) | 1.65 | 0.78‐3.48 | .19 | |||
Stage Ⅲ vs Ⅰ‐Ⅱ | 0.57 | 0.26‐1.27 | .17 | |||
Differentiation (poor vs well moderate) | 1.51 | 0.68‐3.35 | .31 | |||
EGFR mutation status (mutated vs wild‐type) | 2.27 | 1.04‐4.95 | .04 | 2.53 | 1.15‐5.57 | .02 |
Abbreviations: CI, confidence interval; EGFR, epidermal growth factor receptor; HR, hazard ratio; NSCLC, non‐small cell lung cancer.